Related Experiment Video

Updated: Mar 9, 2026

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

12.5K

The safety of Cervarix? - Authors' reply

Cosette M Wheeler1, Frank Struyf2,

  • 1Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

The Lancet. Infectious Diseases
|December 22, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K
External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
09:35

Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts

Published on: March 2, 2017

12.5K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K
External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K

Related Concept Videos

Vaccinations01:51

Vaccinations

53.0K
Overview
53.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Allergic Reactions02:06

Allergic Reactions

33.1K
Overview
33.1K
What are Viruses?00:50

What are Viruses?

129.3K
Overview
129.3K
Cross-reactivity00:42

Cross-reactivity

33.6K
Overview
33.6K
Humoral Immune Responses01:36

Humoral Immune Responses

85.2K
Overview
85.2K

Articles linked to this work by shared authors, journal, and citation graph.

Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial.

Human vaccines & immunotherapeutics·2026

Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection.

EBioMedicine·2026

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.

iScience·2025

Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023-February 2024.

Human vaccines & immunotherapeutics·2025

Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy.

Human vaccines & immunotherapeutics·2025

Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines.

Communications medicine·2025

Guiding principles for pragmatic randomised trials of tuberculosis treatments.

The Lancet. Infectious diseases·2026

Clinical, molecular, and in vitro evidence of artemisinin partial resistance in Ethiopian Plasmodium falciparum: a prospective, multisite, surveillance study.

The Lancet. Infectious diseases·2026

Efficacy, immunogenicity, and safety of the 9-valent human papillomavirus vaccine in males aged 16-26 years in Japan: a randomised, double-blind, placebo-controlled trial.

The Lancet. Infectious diseases·2026

A review of Bundibugyo virus and the 2026 outbreak: lessons for epidemic preparedness.

The Lancet. Infectious diseases·2026

Impact of directly observed treatment and extended age range of seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in Burkina Faso: a three-group, open-label, cluster-randomised, controlled trial.

The Lancet. Infectious diseases·2026

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

The Lancet. Infectious diseases·2026

Redox-Active SnMoSx Chalcogels for Multi-Electron Reductive Separation of Chromate and Pertechnetate.

Small (Weinheim an der Bergstrasse, Germany)·2026

Organic counterion-induced micellar stabilization in gemini surfactants: synergistic binding of azo dye anions.

Physical chemistry chemical physics : PCCP·2026

Ultrasonic manipulation of solution-state ionomer aggregates for optimized doping efficiency in sulfonated polyphenylsulfone hybrid PEMs.

Chemical communications (Cambridge, England)·2026

Searching for a Correlation between Interfacial Liquid Structure and Hydrodynamic Slip: A Case Study of Water/Silica Interface.

The journal of physical chemistry. C, Nanomaterials and interfaces·2026

Development of Curcumin-Loaded Hybrid Lipid-Polymeric Nanoparticles for Hypoxia-Related Applications.

International journal of nanomedicine·2026

Remediation of polyvinyl chloride from water by UV/sulfate radical-based advanced oxidation process.

Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us